☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
WW
Pfizer Signs a WW License Agreement with Pyxis to Develop and Commercialize Two ADC Candidates
March 19, 2021
Novartis Signs Worldwide License Agreement with Forendo Pharma to Discover Therapies Targeting Chronic Liver Diseases
December 12, 2019
AstraZeneca Signs a Worldwide Development and Commercialization Agreement with Daiichi Sankyo for $6.9B
March 29, 2019
AbbVie Signs an Exclusive Worldwide Research Collaboration with Voyager Therapeutics for Vectorized Abs
February 25, 2019
Nestle Health Science (NHSc) Exercises its Exclusive WorldWide Option to License CDX-6114 from Codexis
February 15, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.